|Articles|April 1, 2012
- BioPharm International-04-01-2012
- Volume 25
- Issue 4
BioPharm International, April 2012 Issue (PDF)
Optimizing Filtration Strategies
Advertisement
Articles in this issue
over 13 years ago
A Strong Start to 2012over 13 years ago
Pointed Debateover 13 years ago
Optimizing Adjuvant Filtrationover 13 years ago
The Growing Orphan-Drug Paradigmover 13 years ago
Manufacturers Wrestle with Drug Abuse and Critical Shortagesover 13 years ago
Small Changes, System-Wide Impactover 13 years ago
Knowledge Management Implementationover 13 years ago
Ways to Recover Lost Marginsover 13 years ago
Single-Use Redundant FiltrationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
